Fig. 6From: How to design a dose-finding study using the continual reassessment methodResults from the dose-finding trial of ssHHT in patients with advanced acute myeloid leukaemia [63] a) Trial conduct and DLTs observed. b) Final posterior mean estimates of DLT probabilities and 95% credible intervals (2.5th and 97.5th percentiles).Back to article page